Literature DB >> 19707732

Small-molecule costimulatory blockade: organic dye inhibitors of the CD40-CD154 interaction.

Emilio Margolles-Clark1, Oliver Umland, Norma S Kenyon, Camillo Ricordi, Peter Buchwald.   

Abstract

Costimulatory blockade is one of the most promising therapeutic targets in autoimmune diseases as well as in transplant recipients, and inhibition of the cluster of differentiation (CD)40-CD154 interaction, which is required for T cell activation and development of an effective immune response, is particularly promising in islet transplant recipients. Here, we report the ability of several small-molecule organic dyes to concentration dependently inhibit this interaction with IC(50) values in the low-micromolar range. They were found to be considerably more active in inhibiting this interaction than the tumor necrosis factor (TNF)-R1-TNF-alpha or B cell-activating factor (BAFF)-R-BAFF interaction, which are members of the same family. They specifically inhibited CD154-induced cell responses in human B cells as well as in THP-1 myeloid cells, which can serve as surrogate dendritic cells, at concentrations well below their cytotoxic concentrations determined in the same cells. Flow cytometry experiments confirmed their ability to inhibit the CD154-induced, but not the Staphylococcus aureus Cowan I- or phorbol 12-myristate 13-acetate-induced increase in the surface expression of CD54, CD40, and major histocompatibility complex class II. Accordingly, these compounds can be useful not only for experimental investigations involving the inhibition of the CD40-CD154 costimulatory interaction but can also provide important structure-activity relationship information and can serve as the starting point of a targeted drug discovery program.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19707732     DOI: 10.1007/s00109-009-0519-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  33 in total

1.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

Authors:  Susan L McGovern; Emilia Caselli; Nikolaus Grigorieff; Brian K Shoichet
Journal:  J Med Chem       Date:  2002-04-11       Impact factor: 7.446

Review 2.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

3.  A detergent-based assay for the detection of promiscuous inhibitors.

Authors:  Brian Y Feng; Brian K Shoichet
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 4.  Scaffolds for blocking protein-protein interactions.

Authors:  Stefan J Hershberger; Song-Gil Lee; Jean Chmielewski
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

5.  Identification of three novel peptides that inhibit CD40-CD154 interaction.

Authors:  Minetake Kitagawa; Daisuke Goto; Mizuko Mamura; Isao Matsumoto; Satoshi Ito; Akito Tsutsumi; Takayuki Sumida
Journal:  Mod Rheumatol       Date:  2005       Impact factor: 3.023

6.  Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways.

Authors:  Kenneth Cardona; Gregory S Korbutt; Zvonimir Milas; James Lyon; Jose Cano; Wanhong Jiang; Hameeda Bello-Laborn; Brad Hacquoil; Elizabeth Strobert; Shivaprakash Gangappa; Collin J Weber; Thomas C Pearson; Ray V Rajotte; Christian P Larsen
Journal:  Nat Med       Date:  2006-02-26       Impact factor: 53.440

Review 7.  Recognition of Staphylococcus aureus by the innate immune system.

Authors:  Bénédicte Fournier; Dana J Philpott
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

Review 8.  Costimulatory pathways in transplantation: challenges and new developments.

Authors:  Xian C Li; David M Rothstein; Mohamed H Sayegh
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

9.  Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.

Authors:  Hélène Bour-Jordan; Benoît L Salomon; Heather L Thompson; Gregory L Szot; Matthew R Bernhard; Jeffrey A Bluestone
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  Role of TNF-alpha and extracellular ATP in THP-1 cell activation following allergen exposure.

Authors:  Masaaki Miyazawa; Yuichi Ito; Nanae Kosaka; Yuko Nukada; Hitoshi Sakaguchi; Hiroyuki Suzuki; Naohiro Nishiyama
Journal:  J Toxicol Sci       Date:  2008-02       Impact factor: 2.196

View more
  16 in total

Review 1.  Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions.

Authors:  Damir Bojadzic; Peter Buchwald
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

2.  A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis.

Authors:  Gisela M Vaitaitis; Martin G Yussman; David H Wagner
Journal:  J Neuroimmunol       Date:  2019-03-21       Impact factor: 3.478

3.  Small-molecule modulators of the OX40-OX40 ligand co-stimulatory protein-protein interaction.

Authors:  Yun Song; Emilio Margolles-Clark; Allison Bayer; Peter Buchwald
Journal:  Br J Pharmacol       Date:  2014-11       Impact factor: 8.739

4.  Small molecule inhibition of the TNF family cytokine CD40 ligand through a subunit fracture mechanism.

Authors:  Laura F Silvian; Jessica E Friedman; Kathy Strauch; Teresa G Cachero; Eric S Day; Fang Qian; Brian Cunningham; Amy Fung; Lihong Sun; Gerald W Shipps; Lihe Su; Zhongli Zheng; Gnanasambandam Kumaravel; Adrian Whitty
Journal:  ACS Chem Biol       Date:  2011-04-20       Impact factor: 5.100

Review 5.  TNF superfamily protein-protein interactions: feasibility of small- molecule modulation.

Authors:  Yun Song; Peter Buchwald
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

6.  Targeted disruption of Cd40 in a genetically hypertensive rat model attenuates renal fibrosis and proteinuria, independent of blood pressure.

Authors:  Steven T Haller; Sivarajan Kumarasamy; David A Folt; Leah M Wuescher; Stanislaw Stepkowski; Manish Karamchandani; Harshal Waghulde; Blair Mell; Muhammad Chaudhry; Kyle Maxwell; Siddhi Upadhyaya; Christopher A Drummond; Jiang Tian; Wanda E Filipiak; Thomas L Saunders; Joseph I Shapiro; Bina Joe; Christopher J Cooper
Journal:  Kidney Int       Date:  2016-09-28       Impact factor: 10.612

7.  The promiscuous protein binding ability of erythrosine B studied by metachromasy (metachromasia).

Authors:  Lakshmi Ganesan; Peter Buchwald
Journal:  J Mol Recognit       Date:  2013-04       Impact factor: 2.137

Review 8.  Advances in targeting cell surface signalling molecules for immune modulation.

Authors:  Sheng Yao; Yuwen Zhu; Lieping Chen
Journal:  Nat Rev Drug Discov       Date:  2013-02       Impact factor: 84.694

9.  Effects of representative glucocorticoids on TNFα- and CD40L-induced NF-κB activation in sensor cells.

Authors:  Sirlene R Cechin; Peter Buchwald
Journal:  Steroids       Date:  2014-04-18       Impact factor: 2.668

10.  A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice.

Authors:  Gisela M Vaitaitis; Michael H Olmstead; Dan M Waid; Jessica R Carter; David H Wagner
Journal:  Diabetologia       Date:  2014-08-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.